Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE biomarker assay received a Letter of Support (LoS ...

Futures inched higher while bitcoin topped $80,000 as the Donald Trump rally continues. Nvidia, Meta lead five stocks near buy points.

Developing a vaccination program for infectious bursal disease virus (IBDV) challenges should consider the severity and ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

Google stock has gained 28% in 2024 but shares have ping-ponged since July amid fierce AI competition and antitrust worries.

Alcohol can worsen Crohn’s disease symptoms, but the impact varies from person to person. It may depend on what and how much ...

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients involves trial and error during the treatment process.

DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...